British American Tobacco Financial Statements (BTI)
|
|
Report date
|
|
|
31.12.2021 |
08.03.2022 |
31.12.2022 |
02.03.2023 |
09.02.2024 |
|
25.07.2024 |
Currency
|
|
|
GBP |
GBP |
GBP |
GBP |
GBP |
|
GBP |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, £ |
? |
|
34 732 984 434 |
25 684 000 000 |
27 655 000 000 |
27 655 000 000 |
27 283 000 000 |
|
40 024 000 000 |
Operating Income, £ |
|
|
14 818 721 516 |
10 234 000 000 |
10 523 000 000 |
10 523 000 000 |
-15 751 000 000 |
|
17 126 000 000 |
EBITDA, £ |
? |
|
16 211 611 018 |
11 673 000 000 |
12 714 000 000 |
12 292 000 000 |
8 826 000 000 |
|
16 127 500 000 |
Net profit, £ |
? |
|
9 180 899 833 |
6 801 000 000 |
6 666 000 000 |
6 666 000 000 |
-14 367 000 000 |
|
-32 216 500 000 |
|
OCF, £ |
? |
|
9 717 000 000 |
9 717 000 000 |
10 394 000 000 |
10 394 000 000 |
10 714 000 000 |
|
10 504 000 000 |
CAPEX, £ |
? |
|
745 000 000 |
527 000 000 |
656 000 000 |
523 000 000 |
460 000 000 |
|
466 000 000 |
FCF, £ |
? |
|
8 972 000 000 |
9 190 000 000 |
9 738 000 000 |
9 871 000 000 |
10 254 000 000 |
|
10 038 000 000 |
Dividend payout, £
|
|
|
4 904 000 000 |
4 904 000 000 |
4 915 000 000 |
4 915 000 000 |
5 055 000 000 |
|
7 757 000 000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
53.4% |
72.1% |
73.7% |
73.7% |
0.00% |
|
-24.1% |
|
OPEX, £ |
|
|
14 183 131 161 |
11 065 000 000 |
7 822 000 000 |
7 822 000 000 |
38 143 000 000 |
|
11 516 000 000 |
Cost of production, £ |
|
|
6 216 614 602 |
4 382 000 000 |
4 554 000 000 |
4 554 000 000 |
4 641 000 000 |
|
10 322 000 000 |
R&D, £ |
|
|
411 105 251 |
141 000 000 |
138 000 000 |
138 000 000 |
181 000 000 |
|
382 000 000 |
Interest expenses, £ |
|
|
1 941 931 383 |
1 521 000 000 |
1 663 000 000 |
1 663 000 000 |
1 887 000 000 |
|
2 965 000 000 |
|
Assets, £ |
|
|
0.000 |
137 365 000 000 |
153 546 000 000 |
153 546 000 000 |
118 716 000 000 |
|
119 369 000 000 |
Net Assets, £ |
? |
|
67 545 674 604 |
67 101 000 000 |
75 368 000 000 |
75 368 000 000 |
52 566 000 000 |
|
54 111 000 000 |
Debt, £ |
|
|
|
39 658 000 000 |
43 139 000 000 |
43 139 000 000 |
39 730 000 000 |
|
40 385 000 000 |
Cash, £ |
|
|
4 415 324 489 |
3 265 000 000 |
4 025 000 000 |
4 025 000 000 |
5 260 000 000 |
|
6 630 000 000 |
Net debt, £ |
|
|
-4 415 324 489 |
36 393 000 000 |
39 114 000 000 |
39 114 000 000 |
34 470 000 000 |
|
33 755 000 000 |
|
Ordinary share price, rub |
|
|
37.4 |
37.4 |
40.0 |
40.0 |
29.3 |
|
41.2 |
Number of ordinary shares, mln |
|
|
2 296 684 708 |
2 287 000 000 |
2 266 872 216 |
2 256 000 000 |
2 221 930 095 |
|
2 232 151 772 |
|
Market cap, £ |
|
|
85 918 974 926 |
85 556 670 000 |
90 629 551 196 |
90 194 880 000 |
65 080 332 483 |
|
91 897 688 453 |
EV, £ |
? |
|
81 503 650 437 |
121 949 670 000 |
129 743 551 196 |
129 308 880 000 |
99 550 332 483 |
|
125 652 688 453 |
Book value, £ |
|
|
-88 816 314 387 |
-48 524 000 000 |
-53 707 000 000 |
-53 707 000 000 |
-42 996 000 000 |
|
-40 589 000 000 |
|
EPS, rub |
? |
|
4.00 |
2.97 |
2.94 |
2.95 |
-6.47 |
|
-14.4 |
FCF/share, rub |
|
|
3.91 |
4.02 |
4.30 |
4.38 |
4.61 |
|
4.50 |
BV/share, rub |
|
|
-38.7 |
-21.2 |
-23.7 |
-23.8 |
-19.4 |
|
-18.2 |
|
EBITDA margin, % |
? |
|
46.7% |
45.4% |
46.0% |
44.4% |
32.3% |
|
40.3% |
Net margin, % |
? |
|
26.4% |
26.5% |
24.1% |
24.1% |
-52.7% |
|
-80.5% |
FCF yield, % |
? |
|
10.4% |
10.7% |
10.7% |
10.9% |
15.8% |
|
10.9% |
ROE, % |
? |
|
13.6% |
10.1% |
8.84% |
8.84% |
-27.3% |
|
-59.5% |
ROA, % |
? |
|
|
4.95% |
4.34% |
4.34% |
-12.1% |
|
-27.0% |
|
P/E |
? |
|
9.36 |
12.6 |
13.6 |
13.5 |
-4.53 |
|
-2.85 |
P/FCF |
|
|
9.58 |
9.31 |
9.31 |
9.14 |
6.35 |
|
9.15 |
P/S |
? |
|
2.47 |
3.33 |
3.28 |
3.26 |
2.39 |
|
2.30 |
P/BV |
? |
|
-0.97 |
-1.76 |
-1.69 |
-1.68 |
-1.51 |
|
-2.26 |
EV/EBITDA |
? |
|
5.03 |
10.4 |
10.2 |
10.5 |
11.3 |
|
7.79 |
Debt/EBITDA |
|
|
-0.27 |
3.12 |
3.08 |
3.18 |
3.91 |
|
2.09 |
|
R&D/CAPEX, % |
|
|
55.2% |
26.8% |
21.0% |
26.4% |
39.3% |
|
82.0% |
|
CAPEX/Revenue, % |
|
|
2.14% |
2.05% |
2.37% |
1.89% |
1.69% |
|
1.16% |
|
British American Tobacco shareholders |